Stock Report: China Cord Blood Corp. (CO) Report Updated: May 13, 2013 | Print This Page
Report Features:
Stock Analysis
Rating: Monthly View
| A |  |
|
 |
|
|
 |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | ||||||||||||
| C | ||||||||||||
| D | ||||||||||||
| F | ||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Rating: Weekly View
| This Week: | C  no change |
|---|---|
| Last Week: | C no change |
| Two Weeks Ago: | C no change |
Company Profile
China Cord Blood Corporation, together with its subsidiaries, engages in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It offers cord blood testing, processing, and storage services under the direction of subscribers; laboratory testing, hematopoietic stem cell processing, and stem cell storage services; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2012, the company had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. China Cord Blood Corporation is based in Central, Hong Kong.
Recent News: China Cord Blood Corp.
| 2012-10-22 16:01:00 | China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2012 |
| 2012-10-22 07:00:00 | China Cord Blood Corporation Continues Share Repurchase Program |
| 2012-10-05 00:00:00 | Amendment to a SC 13D filing - Form SC 13D/A |
| 2012-10-04 00:00:00 | Amendment to a SC 13D filing - Form SC 13D/A |
| 2012-10-03 08:00:00 | China Cord Blood Corporation Announces Completion of $50 Million Convertible Note Financing with Golden Meditech |
My Portfolios (View All)
Save your portfolio—or a few for that matter—and check up on your stocks 24/7! Log in here.
Louis Navellier's Portfolios
- Blue Chip GrowthTop blue chips
- Emerging GrowthTop small-caps
- Ultimate GrowthFastest-moving
- Platinum GrowthElite Model Portfolio